Introduction
Thrombelastography (TEG) has been used to characterize the coagulation changes associated with injury and shock. Animal models developed to investigate trauma-induced coagulopathy (TIC) have failed to produce excessive bleeding. We hypothesize that a native TEG will demonstrate marked differences in humans compared to these experimental models, which explains the difficulties in reproducing a clinically relevant coagulopathy in animal models.
Methods
Whole blood was collected from 138 healthy human volunteers, 25 swine and 66 Sprague Dawley rats prior to experimentation. Citrated native TEGs were conducted on each whole blood sample within 2 hours of collection. The clot initiation (R-time, min), angle (degrees), MA (mm), and LY30 (%) were analyzed and contrasted between species with data represented as the median and 25th to 75th quartile range. Difference between species was conducted with a Kruskall Wallis test with alpha adjusted with a Bonferroni correction for multiple comparisons (alpha = 0.016).
Results
Median R-Time (clot initiation) 14.65 min (IQR: 13.2–16.3 min) for humans, 5.7 (4.9–8.8) for pigs, and 5.2 (4.4–6) for rodents. Humans had longer R-Times than both pigs (p<0.0001) and rats (p<0.0001); pigs were not different from rats (p= 0.4439). Angle (fibrin cross-linking) was 42.3 degrees (IQR: 37.5–50.2) for humans, 71.7 (64.3–75.6) for pigs, and 61.8 (56.8–66.7) for rats. Humans had reduced Angle compared to both pigs (p<0.0001) and rats (p<0.0001); pigs were not different from rats (p=0.6052). MA (clot strength) was 55.5 mm (IQR: 52.0–59.5 for humans, 72.5 (70.4–75.5) for pigs, and 66.5 (56.5–68.6) for rats. Humans had reduced MA compared to both pigs (p<0.0001) and rats (p<0.0001); pigs were not different from rats (p=0.0161). LY30 (fibrinolysis) was 1.5 % (IQR: 0.975–2.5) for humans, 3.3 (1.9–4.3) for pigs, and 0.5 (0.1–1.2) for rats. Humans had a lesser LY30 than pigs (p=0.0062) and a greater LY30 than rats (p<0.0001), and pigs had a greater LY30 than rats (p<0.0001).
Conclusion
Humans, swine, and rodents have distinctly different coagulation systems, when evaluated by citrated native TEG. Animals are hypercoagulable with rapid clotting times and clots strengths nearly 50% stronger than humans. These coagulation differences indicate the limitations of previous models of TIC in producing coagulation abnormalities associated with increased bleeding. The inherent hypercoagulable baseline tendencies of these animals may result in subclinical biochemical changes that are not detected by conventional TEG and should be taken into consideration when extrapolated to clinical medicine.